Comparing Two Ways to Set Exercise Levels in Chronic Obstructive Pulmonary Disease
Compares two methods of planning exercise in adults with chronic obstructive pulmonary disease.
Key facts
- Who runs it
- Aveiro University
- Where
- Aveiro, PortugalSee the site
- Trial code
- Registry title
- FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease
- Status
- Not yet recruiting
- People taking part
- 46 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 31 Jul 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Pulmonary rehabilitation programme
- Record updated
- 1 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a clinical diagnosis of COPD who can complete a maximal exercise test and join a pulmonary rehabilitation programme.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Clinical diagnosis of COPD
- Earlier treatment
- Cannot have taken part in pulmonary rehabilitation in the last 12 months
- Biomarker or test result
- Must complete a maximal exercise test (CPET) in which the first metabolic threshold (MT1) is identified
Main reasons for not taking part
- Unstable or significant conditions (for example muscle, bone, nerve, heart, cancer or immune conditions) that make the rehabilitation programme not possible
- Took part in pulmonary rehabilitation in the last 12 months
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Clinical diagnosis of COPD
- Complete a maximal CPET with MT1 identification
Who cannot take part
- Presence of unstable or significant conditions (e.g. musculoskeletal, neurological, cardiovascular, neoplasia or immunological) that renders the participation in the pulmonary rehabilitation program infeasible
- Participated in pulmonary rehabilitation in the last 12 months
Where in Portugal
- University of AveiroAveiro, PortugalContact: Alda S Marques, PhDNot yet recruiting
About the trial
What the trial wants to find out
This randomised controlled trial aims to: i) compare the power output at the first metabolic threshold (WMT1) between the MT1 and the six-minute walking test (6MWT)-based cardiorespiratory exercise prescriptions in chronic obstructive pulmonary disease (COPD); ii) compare exercise adherence, peripheral muscle strength, health-related quality of life, dyspnoea, fatigue, disease impact and emotional status between MT1 and 6MWT-based exercise prescriptions.
Read full original descriptionShow less
Patients will be recruited via the pulmonology services from Unidade Local de Saúde do Baixo Mondego and Unidade Local de Saúde de Aveiro.
The 2 groups in the trial
- Metabolic Threshold-based exercise intensity prescriptionTreatment being tested
Treatment: Pulmonary rehabilitation programme
- Six-minute walking test-based exercise intensity prescriptionExisting treatment, for comparison
Treatment: Pulmonary rehabilitation programme
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease
- Plain-language title
- Comparing Two Ways to Set Exercise Levels in Chronic Obstructive Pulmonary DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 1 September 2026